Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: A cross-sectional study

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Giardino, Nicholas D ^a,c   Curtis, Jeffrey L ^a,b   Andrei, Adin Cristian ^b   Fan, Vincent S ^d   Benditt, Joshua O ^d   Lyubkin, Mark ^a,c   Naunheim, Keith ^e   Criner, Gerard ^f   Make, Barry ^g   Wise, Robert A ^h   Murray, Susan K ^b   Fishman, Alfred P ⁱ   Sciurba, Frank C ^j   Liberzon, Israel ^a,c   Martinez, Fernando J ^b  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f TEMPLE UNIVERSITY   (United States)

^g UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; BICYCLE ERGOMETRY; CONFOUNDING VARIABLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DYSPNEA; EMPHYSEMA; ERGOMETRY PEAK WORKLOAD; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTION TEST; FUNCTIONAL STATUS; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREDICTION; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORTNESS OF BREATH QUESTIONNAIRE; SIX MINUTE WALK DISTANCE TEST; ST GEORGES RESPIRATORY QUESTIONNAIRE; STATE TRAIT ANXIETY INVENTORY; WORK CAPACITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; INCIDENCE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

AGED; ANXIETY; COMORBIDITY; CROSS-SECTIONAL STUDIES; EMPHYSEMA; EXERCISE TOLERANCE; FEMALE; HUMANS; INCIDENCE; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 77952471803     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-29     Document Type: Article

References (67)

1. Prigatano GP, Wright EC, Levin D. Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch Intern Med 1984, 144:1613-1619. 10.1001/archinte.144.8.1613, 6380440.
2. Monso E, Fiz JM, Izquierdo J, Alonso J, Coll R, Rosell A, Morera J. Quality of life in severe chronic obstructive pulmonary disease: correlation with lung and muscle function. Respir Med 1998, 92:221-227. 10.1016/S0954-6111(98)90099-3, 9616516.
3. McSweeny AJ, Grant I, Heaton RK, Adams KM, Timms RM. Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med 1982, 142:473-478. 10.1001/archinte.142.3.473, 7065785.
4. Felker B, Katon W, Hedrick SC, Rasmussen J, McKnight K, McDonnell MB, Fihn SD. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry 2001, 23:56-61. 10.1016/S0163-8343(01)00127-X, 11313071.
5. Cully JA, Graham DP, Stanley MA, Ferguson CJ, Sharafkhaneh A, Souchek J, Kunik ME. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2006, 47:312-319. 10.1176/appi.psy.47.4.312, 16844889.
6. Beck JG, Scott SK, Teague RB, Perez FI. Correlates of daily impairment in COPD. Rehabil Psychol 1988, 33:77-84.
7. Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, Petersen NJ, Nahas Z, Goodnight-White S. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000, 41:465-471. 10.1176/appi.psy.41.6.465, 11110109.
8. Dahlen I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 2002, 122:1633-1637. 10.1378/chest.122.5.1633, 12426264.
9. Borak J, Chodosowska E, Matuszewski A, Zielinski J. Emotional status does not alter exercise tolerance in patients with chronic obstructive pulmonary disease. Eur Respir J 1998, 12:370-373.
10. Engstrom CP, Persson LO, Larsson S, Ryden A, Sullivan M. Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study. Thorax 1996, 51:825-830. 10.1136/thx.51.8.825, 472558, 8795672.
11. Withers NJ, Rudkin ST, White RJ. Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation. J Cardiopulm Rehabil 1999, 19:362-365. 10.1097/00008483-199911000-00007, 10609186.
12. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry 2000, 15:1090-1096. 10.1002/1099-1166(200012)15:12<1090::AID-GPS249>3.0.CO;2-L, 11180464.
13. Kvaal K, Macijauskiene J, Engedal K, Laake K. High prevalence of anxiety symptoms in hospitalized geriatric patients. Int J Geriatr Psychiatry 2001, 16:690-693. 10.1002/gps.405, 11466747.
14. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006, 31:58-69. 10.1016/j.jpainsymman.2005.06.007, 16442483.
15. Karajgi B, Rifkin A, Doddi S, Kolli R. The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Am J Psychiatry 1990, 147:200-201.
16. Moore MC, Zebb BJ. The catastrophic misinterpretation of physiological distress. Behaviour Research and Therapy 1999, 37:1105-1118. 10.1016/S0005-7967(98)00197-1, 10500323.
17. Yellowlees PM, Haynes S, Potts N, Ruffin RE. Psychiatric morbidity in patients with life-threatening asthma: initial report of a controlled study. Med J Aust 1988, 149:246-249.
18. Watson D, Pennebaker JW. Health complaints, stress, and distress: exploring the central role of negative affectivity. Psychol Rev 1989, 96:234-254. 10.1037/0033-295X.96.2.234, 2710874.
19. Rationale and design of The National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. The National Emphysema Treatment Trial Research Group. Chest 1999, 116:1750-1761. 10.1378/chest.116.6.1750, 10593802.
20. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003, 348:2059-2073. 10.1056/NEJMoa030287, 12759479.
21. Speilberger CD. Manual for the State-Trait Anxiety Inventory 1983, Palo Alto, California: Consulting Psychologists Press.
22. Kellner R, Uhlenhuth EH. The rating and self-rating of anxiety. The British journal of psychiatry 1991, 15-22.
23. Beck AT, Steer RA. Beck Depression Inventory, Revised Edition (BDI) 1971, San Antonio, TX: The Psychological Corporation.
24. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
25. Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest 1998, 113:619-624. 10.1378/chest.113.3.619, 9515834.
26. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995, 152:1107-1136.
27. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update. Am J Respir Crit Care Med 1995, 152:2185-2198.
28. Crapo RO, Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981, 123:185-189.
29. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981, 123:659-664.
30. Sciurba F, Criner GJ, Lee SM, Mohsenifar Z, Shade D, Slivka W, Wise RA. Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med 2003, 167:1522-1527. 10.1164/rccm.200203-166OC, 12615634.
31. Himmelfarb S, Murrell SA. The prevalence and correlates of anxiety symptoms in older adults. J Psychol 1984, 116:159-167.
32. Murrell SA, Himmelfarb S, Wright K. Prevalence of depression and its correlates in older adults. Am J Epidemiol 1983, 117:173-185.
33. Cohen-Cole SA, Stoudemire A. Major depression and physical illness. Special considerations in diagnosis and biologic treatment. Psychiatr Clin North Am 1987, 10:1-17.
34. Cavanaugh S, Clark DC, Gibbons RD. Diagnosing depression in the hospitalized medically ill. Psychosomatics 1983, 24:809-815.
35. Ferrer M, Villasante C, Alonso J, Sobradillo V, Gabriel R, Vilagut G, Masa JF, Viejo JL, Jimenez-Ruiz CA, Miravitlles M. Interpretation of quality of life scores from the St George's Respiratory Questionnaire. Eur Respir J 2002, 19:405-413. 10.1183/09031936.02.00213202, 11936515.
36. Steffen TM, Hacker TA, Mollinger L. Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds. Phys Ther 2002, 82:128-137.
37. von Leupoldt A, Ambruzsova R, Nordmeyer S, Jeske N, Dahme B. Sensory and affective aspects of dyspnea contribute differentially to the Borg scale's measurement of dyspnea. Respiration 2006, 73:762-768.
38. Carrieri-Kohlman V, Gormley JM, Douglas MK, Paul SM, Stulbarg MS. Differentiation between dyspnea and its affective components. Western journal of nursing research 1996, 18:626-642. 10.1177/019394599601800602, 9000871.
39. Giardino ND, Chan L, Borson S. Combined heart rate variability and pulse oximetry biofeedback for chronic obstructive pulmonary disease: preliminary findings. Appl Psychophysiol Biofeedback 2004, 29:121-133. 10.1023/B:APBI.0000026638.64386.89, 15208975.
40. Aydin IO, Ulusahin A. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen Hosp Psychiatry 2001, 23:77-83. 10.1016/S0163-8343(01)00116-5, 11313075.
41. Beck JG, Scott SK, Teague RB, Perez FI, et al. Correlates of daily impairment in COPD. Rehabil Psychol 1988, 33:77-84.
42. Gudmundsson G, Gislason T, Janson C, Lindberg E, Suppli Ulrik C, Brondum E, Nieminen MM, Aine T, Hallin R, Bakke P. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med 2006, 100:87-93. 10.1016/j.rmed.2005.04.003, 15893921.
43. Weaver TE, Richmond TS, Narsavage GL. An explanatory model of functional status in chronic obstructive pulmonary disease. Nurs Res 1997, 46:26-31. 10.1097/00006199-199701000-00005, 9024421.
44. Fan VS, Ramsey SD, Giardino ND, Make BJ, Emery CF, Diaz PT, Benditt JO, Mosenifar Z, McKenna R, Curtis JL, et al. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med 2007, 167:2345-2353. 10.1001/archinte.167.21.2345, 18039994.
45. Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Weinmann G, Kazerooni E, Murray S, Criner GJ, Sin DD, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007, 176:243-252. 10.1164/rccm.200606-828OC, 1994221, 17431226.
46. Isoaho R, Keistinen T, Laippala P, Kivela SL. Chronic obstructive pulmonary disease and symptoms related to depression in elderly persons. Psychol Rep 1995, 76:287-297.
47. de Torres JP, Casanova C, Hernandez C, Abreu J, Aguirre-Jaime A, Celli BR. Gender and COPD in patients attending a pulmonary clinic. Chest 2005, 128:2012-2016. 10.1378/chest.128.4.2012, 16236849.
48. Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, Allegra L, Centanni S. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med 2006, 100:1767-1774. 10.1016/j.rmed.2006.01.026, 16531031.
49. Stahl E, Lindberg A, Jansson SA, Ronmark E, Svensson K, Andersson F, Lofdahl CG, Lundback B. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes 2005, 3:56. 10.1186/1477-7525-3-56, 1215504, 16153294.
50. Neuman A, Gunnbjornsdottir M, Tunsater A, Nystrom L, Franklin KA, Norrman E, Janson C. Dyspnea in relation to symptoms of anxiety and depression: A prospective population study. Respir Med 2006, 100:1843-1849. 10.1016/j.rmed.2006.01.016, 16516455.
51. Porzelius J, Vest M, Nochomovitz M. Respiratory function, cognitions, and panic in chronic obstructive pulmonary patients. Behav Res Ther 1992, 30:75-77. 10.1016/0005-7967(92)90101-L, 1540118.
52. Giardino ND, Borson S, Von Korff M, Chan L. Beliefs about breathlessness are associated with disability in COPD. American Thoracic Society annual meeting, May 2004; Orlando, FL
53. Shekhar A, Sajdyk TJ, Gehlert DR, Rainnie DG. The amygdala, panic disorder, and cardiovascular responses. Ann N Y Acad Sci 2003, 985:308-325.
54. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006, 119:21-31. 10.1016/j.amjmed.2006.08.004, 16996896.
55. Means-Christensen AJ, Sherbourne CD, Roy-Byrne PP, Craske MG, Stein MB. Using five questions to screen for five common mental disorders in primary care: diagnostic accuracy of the Anxiety and Depression Detector. Gen Hosp Psychiatry 2006, 28:108-118. 10.1016/j.genhosppsych.2005.08.010, 16516060.
56. Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, VanTuinen C. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 1992, 33:190-201.
57. Argyropoulou P, Patakas D, Koukou A, Vasiliadis P, Georgopoulos D. Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration 1993, 60:216-220. 10.1159/000196202, 8265878.
58. Papp LA, Weiss JR, Greenberg HE, Rifkin A, Scharf SM, Gorman JM, Klein DF. Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders. Am J Psychiatry 1995, 152:1531.
59. Smoller JW, Pollack MH, Systrom D, Kradin RL. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics 1998, 39:24-29.
60. Kunik ME, Braun U, Stanley MA, Wristers K, Molinari V, Stoebner D, Orengo CA. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med 2001, 31:717-723. 10.1017/S0033291701003890, 11352373.
61. de Godoy DV, de Godoy RF. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2003, 84:1154-1157. 10.1016/S0003-9993(03)00239-9, 12917854.
62. Emery CF. Effects of age on physiological and psychological functioning among COPD patients in an exercise program. J Aging Health 1994, 6:3-16. 10.1177/089826439400600101, 11890183.
63. Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol 1998, 17:232-240. 10.1037/0278-6133.17.3.232, 9619472.
64. Emery CF, Shermer RL, Hauck ER, Hsiao ET, MacIntyre NR. Cognitive and psychological outcomes of exercise in a 1-year follow-up study of patients with chronic obstructive pulmonary disease. Health Psychol 2003, 22:598-604. 10.1037/0278-6133.22.6.598, 14640857.
65. Guell R, Resqueti V, Sangenis M, Morante F, Martorell B, Casan P, Guyatt GH. Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest 2006, 129:899-904. 10.1378/chest.129.4.899, 16608936.
66. Kayahan B, Karapolat H, Atyntoprak E, Atasever A, Ozturk O. Psychological outcomes of an outpatient pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease. Respir Med 2006, 100:1050-1057. 10.1016/j.rmed.2005.09.031, 16253496.
67. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117.